Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling
<h3>Background</h3> <p>To reduce expenditure on, and wastage of, drugs, some commissioners have encouraged general practitioners to issue shorter prescriptions, typically 28 days in length; however, the evidence base for this recommendation is uncertain.</p> <h3>Objecti...
Auteurs principaux: | Miani, C, Martin, A, Exley, J, Doble, B, Wilson, E, Payne, R, Avery, A, Meads, C, Kirtley, A, Jones, M, King, S |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
NIHR Health Technology Assessment Programme
2017
|
Documents similaires
-
Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling
par: Céline Miani, et autres
Publié: (2017-12-01) -
Transfusion of red blood cells stored for shorter versus longer duration for all conditions
par: Shah, A, et autres
Publié: (2018) -
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI
par: Joe-Elie Salem, et autres
Publié: (2022-09-01) -
Shorter Sleep Predicts Longer Subsequent Day Sedentary Duration in Healthy Midlife Adults, but Not in Those with Sleep Apnea
par: Thosar SS, et autres
Publié: (2021-08-01) -
Overview of systematic reviews assessing the evidence for shorter versus longer duration antibiotic treatment for bacterial infections in secondary care.
par: Igho J Onakpoya, et autres
Publié: (2018-01-01)